Search

You searched for "VUR"

403 results found

Peno-scrotal extramammary Paget’s disease

1 July 2015 | | URO - Infection
Epidemiology Extramammary Paget’s disease (EMP) is a rare intraepithelial neoplasm, which is rarely invasive and has an incidence of six per million person-years as calculated by a European SEER analysis [1]. It usually affects apocrine gland-bearing areas, especially the vulvar,...

Advanced Twitter

1 November 2016 | | URO - Technology
It has been a few years since my post on ‘Twitter for urologists’ was published in Urology News [1]. Given the continued rise of the platform, I thought it was time to revisit and expand on Twitter’s functionality. In this...

Functional and reconstructive urology

4 May 2023 | | URO - Functional / Reconstructive Urology
Case 1 A 45-year-old female presents with a one-year history of urinary leakage, especially worse on coughing. She is otherwise well, with no co-morbidities. What is the International Continence Society (ICS) definition of stress urinary incontinence (SUI)? What are the...

Benign upper tract abnormalities

6 November 2024 | | URO - Functional / Reconstructive Urology
Case 1 A 28-year-old lady has been referred to your clinic with right loin pain. She has no significant past medical history but mentions that she and her partner have been trying to get pregnant. She has an US renal...

BAUS Section of Trainees (BSoT)

3 May 2022
7-9 March 2022 • Edinburgh, UK • Nicholas Boxall, Chair (Elect), BSoT, ST6 Urology, Health Education East of England; and Neil Harvey, BSoT Chair, ST7 Urological Surgery, North West Deanery. The BSoT conference kicked off on Monday 7 March with...

Prostate cancer spit test could save the NHS £500 million a year

15 October 2024 | Research & Development
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home. An innovative new study launched this week,...

Urinary biomarkers for surveillance of non-muscle invasive bladder cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...

Urethroplasty: a review of indications, techniques and outcomes

1 March 2018 | | URO - Functional / Reconstructive Urology
Urethral stricture is the most common cause of lower urinary tract obstruction in men aged between 20 and 40, carrying an estimated overall prevalence of 0.5% in the UK [1] and results in around 17,000 hospital admissions annually [2]. Endoscopic...

Complications of CISC

1 July 2014 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology
Introduction Clean intermittent self catheterisation (CISC) was first introduced and popularised by Lapides in 1972. Since then its utilisation has become widespread and it is now commonly used throughout the world as the preferred means of facilitating complete and effective...

Fournier’s gangrene

1 May 2015 | | URO - Infection
Introduction Fournier’s gangrene (FG) is a rare but fulminant form of infective necrotising fasciitis affecting the perineum and external genitalia, which can rapidly progress along fascial planes. It most commonly affects men, but can occur in women and children, with...

Sustainable healthcare: what steps can urologists take?

3 November 2022 |
Human health is intrinsically linked to environmental health, making the ever-pressing climate crisis fundamentally a public health emergency. The healthcare sector is responsible for 8% of the UK’s greenhouse gas (GHG) emissions worldwide [1]. As the largest publicly funded healthcare...

Adrenal incidentalomas: what next?

8 January 2024 | | URO - Urologic Oncology, URO - Functional / Reconstructive Urology
An incidentaloma refers to an adrenal lesion >1cm discovered incidentally during radiologic examination. Identifying a malignant and / or functioning lesion is critical for management. However, as the majority of lesions are benign, the challenge is the identification of malignant...